N. Afonso

Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial

José Manuel Pérez-García, Géraldine Gebhart, Manuel Ruíz Borrego et al. · The Lancet Oncology · 2021 · 152 citations

Breast Oncology, Medicine, Chemotherapy De-escalation +5

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

Occupational risks for uveal melanoma results from a case-control study in nine European countries

Jean‐Michel Lutz, Ian A. Cree, Svend‎ Sabroe et al. · Cancer Causes & Control · 2005 · 45 citations

Occupational Hygiene, Ophthalmology, Photocarcinogenesis +9

Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study

Nasser Laouali, Corinne Pilorget, Diane Cyr et al. · Scandinavian Journal of Work Environment & Health · 2018 · 45 citations · Full text

Occupational Health Sciences, Exposure Assessment, Cancer Risk Factors +21

Male breast cancer: Looking for better prognostic subgroups

Miguel Henriques Abreu, N. Afonso, Pedro Henriques Abreu et al. · The Breast · 2016 · 44 citations

Breast Oncology, Medicine, Pathology +5